Arrivent Biopharma . Common Stock Stock Forecast

Sell candidate since Aug 10, 2026

The Arrivent Biopharma, Inc. Common Stock stock price gained 0.486% on the last trading day (Monday, 10th Aug 2026), rising from $30.84 to $30.99. During the last trading day the stock fluctuated 2.50% from a day low at $30.37 to a day high of $31.13. The price has been going up and down for this period, and there has been a 2.75% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 162 thousand more shares were traded than the day before. In total, 464 thousand shares were bought and sold for approximately $14.39 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.77% during the next 3 months and, with a 90% probability hold a price between $32.21 and $40.25 at the end of this 3-month period.

AVBP Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, July 20, 2026, and so far it has risen 9.82%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Arrivent Biopharma, Inc. Common Stock stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $32.13. On a fall, the stock will find some support from the short-term average at $30.63. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Arrivent Biopharma, Inc. Common Stock stock

Arrivent Biopharma, Inc. Common Stock finds support from accumulated volume at $30.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.760 between high and low, or 2.50%. For the last week, the stock has had daily average volatility of 5.04%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AVBP) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Arrivent Biopharma, Inc. Common Stock to open at $30.83, and during the day (based on 14 day Average True Range), to move between $30.08 and $31.90, which gives a possible trading interval of +/-$1.82 (+/-6.05%) up or down from last closing price. If Arrivent Biopharma, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 6.05% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $30.68 (1.00%) than the resistance at $32.02 (3.32%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Arrivent Biopharma, Inc. Common Stock stock A Buy?

Arrivent Biopharma, Inc. Common Stock holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.615 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $30.83 ( 0.516%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk